Results 51 to 60 of about 61,152,253 (105)

SARS-CoV-2, a new causative agent of Guillain-Barré syndrome? [PDF]

Med Intensiva (Engl Ed), 2022
Esteban Molina A, Mata Martínez M, Sánchez Chueca P, Carrillo López A.   +3 more
europepmc   +1 more source

[Comment on the article: "Epidemiological and clinical aspects of Guillain-Barré syndrome, 2012-2022"]. [PDF]

Rev Med Inst Mex Seguro Soc
Gómez-Madrigal D.
europepmc   +1 more source

[Guillain-Barré syndrome as an autoimmune neurological manifestation associated with COVID-19: A review of the literature]. [PDF]

Rev Colomb Reumatol, 2022
Naranjo Arango YA, García Henao JP, Farfán Cortés AYAA, Álvarez Correa D.   +3 more
europepmc   +1 more source

Guillain-Barre syndrome associated with previous dengue fever: case report. [PDF]

Rev Peru Med Exp Salud Publica
Sanchez-Landers M, Rodriguez-Benites AF.
europepmc   +1 more source

Oropouche virus - another antecedent event for Guillain-Barré syndrome? [PDF]

Rev Panam Salud Publica
González-Quevedo A, Lestayo O'Farrill Z, Mustelier Becquer R.   +2 more
europepmc   +1 more source

[Guillain-Barré syndrome as the first manifestation of SARS-CoV-2 infection]. [PDF]

Neurologia, 2020
Barrachina-Esteve O, Palau Domínguez A, Hidalgo-Torrico I, Viguera Martínez ML.   +3 more
europepmc   +2 more sources

[Epidemiological and clinical aspects of Guilain-Barré syndrome, 2012-2022]. [PDF]

Rev Med Inst Mex Seguro Soc
Hernández-Jardón CH, Velásquez-Pérez L.   +1 more
europepmc   +1 more source

SARS-CoV-2, A new causative agent of Guillain-Barré syndrome? [PDF]

Med Intensiva (Engl Ed), 2020
Esteban Molina A, Mata Martínez M, Sánchez Chueca P, Carrillo López A.   +3 more
europepmc   +1 more source

[Relation between COVID-19 and Guillain-Barré syndrome in adults. Systematic review]. [PDF]

Neurologia, 2020
Trujillo Gittermann LM, Valenzuela Feris SN, von Oetinger Giacoman A.   +2 more
europepmc   +2 more sources